These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29188576)

  • 21. Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR.
    Sadybekov AA; Brouillette RL; Marin E; Sadybekov AV; Luginina A; Gusach A; Mishin A; Besserer-Offroy É; Longpré JM; Borshchevskiy V; Cherezov V; Sarret P; Katritch V
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein-coupled receptor deorphanizations.
    Civelli O; Reinscheid RK; Zhang Y; Wang Z; Fredriksson R; Schiöth HB
    Annu Rev Pharmacol Toxicol; 2013; 53():127-46. PubMed ID: 23020293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands.
    Costanzi S; Tikhonova IG; Harden TK; Jacobson KA
    J Comput Aided Mol Des; 2009 Nov; 23(11):747-54. PubMed ID: 18483766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs.
    Chen M; Jing Y; Wang L; Feng Z; Xie XQ
    J Chem Inf Model; 2019 Apr; 59(4):1283-1289. PubMed ID: 30835466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GOMoDo: A GPCRs online modeling and docking webserver.
    Sandal M; Duy TP; Cona M; Zung H; Carloni P; Musiani F; Giorgetti A
    PLoS One; 2013; 8(9):e74092. PubMed ID: 24058518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel approaches leading towards peptide GPCR de-orphanisation.
    Hauser AS; Gloriam DE; Bräuner-Osborne H; Foster SR
    Br J Pharmacol; 2020 Mar; 177(5):961-968. PubMed ID: 31863461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrypting orphan GPCR drug discovery via multitask learning.
    Huang WC; Lin WT; Hung MS; Lee JC; Tung CW
    J Cheminform; 2024 Jan; 16(1):10. PubMed ID: 38263092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPCRomics: An Approach to Discover GPCR Drug Targets.
    Insel PA; Sriram K; Gorr MW; Wiley SZ; Michkov A; Salmerón C; Chinn AM
    Trends Pharmacol Sci; 2019 Jun; 40(6):378-387. PubMed ID: 31078319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target.
    Bolinger AA; Frazier A; La JH; Allen JA; Zhou J
    ACS Chem Neurosci; 2023 Sep; 14(18):3318-3334. PubMed ID: 37676000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving homology modeling from low-sequence identity templates in Rosetta: A case study in GPCRs.
    Bender BJ; Marlow B; Meiler J
    PLoS Comput Biol; 2020 Oct; 16(10):e1007597. PubMed ID: 33112852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists.
    Nicoli A; Weber V; Bon C; Steuer A; Gustincich S; Gainetdinov RR; Lang R; Espinoza S; Di Pizio A
    J Chem Inf Model; 2023 Nov; 63(21):6667-6680. PubMed ID: 37847527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond standard molecular dynamics: investigating the molecular mechanisms of G protein-coupled receptors with enhanced molecular dynamics methods.
    Johnston JM; Filizola M
    Adv Exp Med Biol; 2014; 796():95-125. PubMed ID: 24158803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective Use of Empirical Data for Virtual Screening against APJR GPCR Receptor.
    Manoliu LCE; Martin EC; Milac AL; Spiridon L
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Modeling Techniques and In-Silico Drug Discovery.
    Bagchi A
    Methods Mol Biol; 2024; 2719():1-11. PubMed ID: 37803109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Fluorescent AF64394 Analogues Enables Real-Time Binding Studies for the Orphan Class A GPCR GPR3.
    Bresinsky M; Shahraki A; Kolb P; Pockes S; Schihada H
    J Med Chem; 2023 Nov; 66(21):15025-15041. PubMed ID: 37907069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orphan G protein-coupled receptors: the ongoing search for a home.
    Jobe A; Vijayan R
    Front Pharmacol; 2024; 15():1349097. PubMed ID: 38495099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational prediction of alanine scanning and ligand binding energetics in G-protein coupled receptors.
    Boukharta L; Gutiérrez-de-Terán H; Aqvist J
    PLoS Comput Biol; 2014 Apr; 10(4):e1003585. PubMed ID: 24743773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferring molecular inhibition potency with AlphaFold predicted structures.
    Oliveira PF; Guedes RC; Falcao AO
    Sci Rep; 2024 Apr; 14(1):8252. PubMed ID: 38589418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavonoids as G Protein-coupled Receptors Ligands: New Potential Therapeutic Natural Drugs.
    Chda A; Bencheikh R
    Curr Drug Targets; 2023; 24(17):1346-1363. PubMed ID: 38037994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism.
    Costanzi S; Stahr LG; Trivellin G; Stratakis CA
    J Mol Graph Model; 2024 Mar; 127():108676. PubMed ID: 38006624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.